Stockscreener 앱 받기
0.6575
5.96%
-0.0417
시간 외 거래:
.64
-0.0175
-2.66%
전일 마감가:
$0.6992
열려 있는:
$0.6929
하루 거래량:
241.63K
Relative Volume:
0.26
시가총액:
$3.30M
수익:
-
순이익/손실:
$-28.70M
주가수익비율:
-0.0133
EPS:
-49.5275
순현금흐름:
$-3.22M
1주 성능:
-41.56%
1개월 성능:
-55.27%
6개월 성능:
-96.01%
1년 성능:
-97.51%
1일 변동 폭
$0.5483
$0.70
1주일 범위
$0.5483
$1.16
52주 변동 폭
$0.5483
$35.01
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
명칭
Aspire Biopharma Holdings Inc
전화
561-704-8527
주소
23150 FASHION DRIVE, SUITE 232, ESTERO
Compare ASBP vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
0.6575 | 3.51M | 0 | -28.70M | -3.22M | -49.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aspire Biopharma Holdings Inc 주식(ASBP)의 최신 뉴스
Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion - ACCESS Newswire
This caffeine powder skips the drink and is heading to stores nationwide - Stock Titan
Aspire Biopharma Plunges 19.5% on Intraday Freefall: What’s Fueling the Sharp Drop? - Bitget
Aspire subsidiary names John Choe as western sales director By Investing.com - Investing.com South Africa
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - The Stockton Record
Aspire subsidiary names John Choe as western sales director - Investing.com
Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director - ACCESS Newswire
He drove 70% sales growth at Yerbaé — now Buzz Bomb hires him - Stock Titan
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - The Gardner News
Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity - Erie Times-News
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - The Hutchinson News
Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 - Black Hills Pioneer
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Corpus Christi Caller-Times
Aspire Biopharma Launches BUZZ BOMB(TM) Convenience Store Pack - National Today
Aspire Biopharma Holdings, Inc.: Aspire Biopharma's BUZZ BOMB Disrupts Energy Category with New Convenience Store Pack - FinanzNachrichten.de
Aspire Biopharma Holdings Inc (ASBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):